Cosmetic Peptide Synthesis Market- Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

The Cosmetic Peptide Synthesis Market is Segmented by Technology (Solid-Phase, Liquid-Phase, and Hybrid and Recombinant), Application (Anti Ageing, Eye Care, Anti Pigmentation, and Hair Growth), End User (Pharmaceutical & Biotechnology Companies, Contract Development and Manufacturing Organization (CDMO), and Academic and Research Institutes), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above-mentioned segments.

Market Snapshot

Market Snapshot
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The cosmetic peptide synthesis market is expected to register a CAGR of 5.5 % over the forecast period of 2022-2027.

The pandemic has an overall negative impact on the cosmetic industry including the cosmetic peptide synthesis industry. For instance, the research study published in October 2021, titled "Beauty During a Pandemic: The Impact of COVID-19 on the Cosmetic Industry" stated significant differences in cosmetic usage; however, post-COVID predicted usage indicates that cosmetic usage will revert back to pre-COVID levels for eye, lip, and skin cosmetics. Despite that the US Cosmetic Industry expected a significant decline in 2020, usage is predicted to return to pre-COVID results for post intentions. The skincare category had little decline mid-COVID and is expected to increase post-COVID. Implementing skincare products as a new product line is highly recommended due to its sustainability through an industry-changing pandemic. Similarly, another article published in October 2020 in the International Journal of Eating Disorders titled "Understanding impacts of the beauty industry shutdown during COVID-19" stated that the study led by researchers from Swinburne’s Centre for Mental Health (CMH) has found that while most people reported spending less time investing in their appearance since COVID-19 began, individuals with high dysmorphic concern continued to feel self-conscious about their appearance.

Factors such as increasing disorders of eyes and skin are one of the key factors for the growth of the market. According to Glaucoma Research Society of Canada around 400,000 people were suffering from Glaucoma in Canada for the year 2021. According to the same source with increasingly ageing population and an aging baby boom generation, many more people will have glaucoma in the future. This would increase the demand for the cosmpetic peptides. Thus, increasing the growth of the market in the upcoming future. Similarly, according to the Australian Institute of Health and Welfare in 2021, around 16,6878 new cases of melanoma of the skin were diagnosed. The same soucre stated that 9,869 males and 7,009 females were diagnosed. In 2019, the age-standardised mortality rate was 4.5 deaths per 100,000 persons (6.6 for males and 2.8 for females). In 2021, it is estimated that the age-standardised mortality rate will be 4.0 deaths per 100,000 persons (5.6 for males and 2.6 for females). The mortality rate for melanoma of the skin is expected to increase with age. Hence, increasing skin cancer could be avioded by the usage of cosmetic peptides. Thus, increasing prevalence of cancer would increase the market growth in upcoming future.

Awareness is one of the key issue for adopting the cosmetic peptides are people still believes that cosmtics does not provide medicinal benifits. For instance, in December 2021 a paper published in National Library of Medicine stated that there is no conclusive study that proves direct correlation between people suffering from diabetic retinopathy and going for continuous eye screening. Early detection is one of the factors that could provide the treatment for the patients suffering from posterior segment eye disorders however lack of awareness would hinder the growth of the market as patient would start treatment at the later stages. Hence, due to above mentioned factors the market is likely to grow in the future.

Scope of the Report

Cosmetic peptides are a unique class of highly active and specific pharmaceutical compounds, molecularly poised between small molecules and proteins, yet biochemically and therapeutically diverse from both. Bioactive peptides have been widely used in cosmetics to provide whitening, anti-aging, and skin repair effects. The Cosmetic Peptide Synthesis Market is Segmented by Technology (Solid-Phase, Liquid-Phase, and Hybrid and Recombinant), Application (Anti Ageing, Eye Care, Anti Pigmentation, and Hair Growth), End User (Pharmaceutical & Biotechnology Companies, Contract Development and Manufacturing Organization (CDMO), and Academic and Research Institutes), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above-mentioned segments.

By Technology
Solid-Phase
Liquid-Phase
Hybrid and Recombinant
By Application
Anti Ageing
Eye Care
Anti Pigmentation
Hair Growth
By End User
Pharmaceutical and Biotechnology Companies
Contract Development and Manufacturing Organization (CDMO)
Academic and Research Institutes
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Eye Care Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Increasing eye burden is one of the key factors for the growth of the market. For instance, according to the October 2021 report of the World Health Organization, about 2.2 billion people around the world have near or distance vision impairment, of which approximately 1 billion cases of vision impairment can be prevented or could have been prevented which shows the high burden of the cases of vision impairment around the world and possibility of treatment which is why there is a very high demand of the therapeutics for the diseases associated with eyes that are driving the growth of the studied market.

According to the research study published in November 2020, titled “Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future”, glaucoma occurs due to the combination of vascular, genetic, anatomical, and immune factors and is a significant health concern as it can cause irreversible blindness and is the second leading cause of blindness after cataracts. As per the same study, it is estimated that approximately 57.5 million people around the world are affected by the primary open-angle glaucoma (POAG) which is expected to reach 111.8 million by 2040, which is a very significant increase and thus, the demand for effective therapeutics is also expected to increase around the world. Increasing therapuetics demands would increase the consumption of cosmetic peptides which will increase the market growth in the future. 

Ageing is also an additional factor for eye sight related disorder. According to the World Population Ageing Highlight of 2020 published by the United Nations, the global geriatric population (people of age 65 years or more) was 727 million in 2020 and is expected to reach 1.5 billion by the end of the 2050. Thus, growing global geriatric population will have a significant impact on the growth of the studied segment as it is observed that some of the eye disorders are age related and their prevalence was found highest in the ageing population. Increasing ageing populaiton would require to consume higher amount of cosmetic peptides. Hence, due to above mentioned factors the market is likely to grow in the future.

image

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to dominate the overall cosmetic peptide synthesis market throughout the forecast period. The dominance is due to the growing prevalence of eye and skin disorders, and increasing R&D and investment via public and private organizations coupled with awareness programs.

The pharmaceutical sector in the United States has long been a leader in the creation of new medications, and member businesses of the Pharmaceutical Research and Manufacturers of America (PhRMA) continue to remain at the forefront. According to the Pharmaceutical Research and Manufacturers of America 2020, pharmaceutical companies in the United States spent roughly USD 83 billion on R&D in 2019, up from USD 50.7 billion in 2010. According to the data published by the Centers for Disease Control and Prevention (CDC) in 2020 around 4.1 million Americans are affected with diabetic retinopathy, and nearly 900,000 Americans are threatened with vision-damaging retinopathy. Diabetic retinopathy is one of the leading disorders of eye disorders. Increasing prevalence will increase the demand for treatment in huge population which will boost the growth of the market in the country.

Increasing number of skin disorders in the country is a key factor for the growth of the market. For instance, in 2020 a report published by Canadian Dermatology Association stated that around 8,000 people are suffering from Melanoma skin cancer our of which around 4,400 were men and 3,600 were women. Melanoma is now the 7th most common cancer in Canada and one of the few cancers with incidence rates on the rise among Canadians. According to the research study published in October 2019, titled "A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study" stated that placebo-controlled clinical trial confirmed that skin aging could be addressed using nutrients that are able to restore skin hydration, elasticity, and density. Hence, the research suggests that the use of peptides can slow down the decline in collagen production that usually occurs with ageing.

Awareness of dermatology is another factor in the growth of the market. For instance, in May 2022 there are two conferences namely, the “International Conference on Challenges in Dermatology Management in Pediatrics (ICCDMP)” (Montreal, Canada) and the “International Conference on Forensic Pathology and Dermatology (ICFPD)” (Vancouver, Canada) are expected to held. Similarly, there are many conferences in June, July, August, and September followed by conferences in 2023 are expected to held. These conferences would discuss the issues and treatment reated to dermatological disorders. As cosmetics peptides play a crucial role in the treatment of skins, as the numebr of conferences increases the awarenss for skin disoder will increase along with the consumption of the cosmetic peptide related products for those disorders. Hence, this will increase the market growth.

Hence, the above mentioned factors are likely to fuel the market growth in this region across the forecast period, contributing to its outstanding market share in the global cosmetic peptide synthesis market​

Peptide Synthesis Market- Growth Rate by Region

Competitive Landscape

The cosmetic peptide synthesis market is moderately competitive, with several major players. Some companies are expanding their market position by adopting various strategies, such as acquisitions, mergers, and research collaborations, while others are introducing new products to maintain their market share. In May 2019, CEM Corporation launched Liberty PRO, the world’s first-ever large-scale automated microwave peptide synthesizer. The system can synthesize 1 kg of crude peptide per batch utilizing a reaction vessel, with sizes up to 15 liters with unmatched purity, speed, and waste reduction fueling the market revenue share. A few of the major players currently dominating the industry in terms of revenue are AAPPTec, CSBio Company Inc., Biotage AB, Bachem Holding AG, and CEM Corporation.

Recent Development

  • In January 2022, BASF launched Peptovitae, a series of four patented peptides that represent a new generation of scientifically developed biomimetic peptides. The Peptovitae series addresses a wider range of skin concerns than are traditionally associated with the use of peptides.
  • In July 2021, ADOREYES, a Canadian cosmetic brand offering natural beauty enhancing products, ADOREYES Plus Lashes & Brows Enhancing Serums have expanded distribution into New Zealand with its first on the global market Triple Peptide Complex formulations.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Eye and Skin Disorders

      2. 4.2.2 Increasing Research and Development Activities

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulation for Approval of Cosmetic Peptide

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Technology

      1. 5.1.1 Solid-Phase

      2. 5.1.2 Liquid-Phase

      3. 5.1.3 Hybrid and Recombinant

    2. 5.2 By Application

      1. 5.2.1 Anti Ageing

      2. 5.2.2 Eye Care

      3. 5.2.3 Anti Pigmentation

      4. 5.2.4 Hair Growth

    3. 5.3 By End User

      1. 5.3.1 Pharmaceutical and Biotechnology Companies

      2. 5.3.2 Contract Development and Manufacturing Organization (CDMO)

      3. 5.3.3 Academic and Research Institutes

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AAPPTec

      2. 6.1.2 Activotec

      3. 6.1.3 Active Peptide

      4. 6.1.4 Bachem Holding AG

      5. 6.1.5 Bio Basic Inc

      6. 6.1.6 Bio Synthesis

      7. 6.1.7 CEM Corporation

      8. 6.1.8 Creative Peptides

      9. 6.1.9 CSBio Company Inc.

      10. 6.1.10 GenScript

      11. 6.1.11 Merck KGaA

      12. 6.1.12 RS Synthesis, LLC

      13. 6.1.13 vivitide

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Cosmetic Peptide Synthesis Market market is studied from 2019 - 2027.

The Global Cosmetic Peptide Synthesis Market is growing at a CAGR of 5.5% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

CSBio Company Inc., AAPPTec, Bachem Holding AG, CEM Corporation, Biotage AB are the major companies operating in Global Cosmetic Peptide Synthesis Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!